| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0054 | 1 |